Demant
Market Cap
ø36.2b
Last Updated
2020/03/31 20:43 UTC
Data Sources
Company Financials +
Executive Summary
Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people’s hearing in Europe, North America, the Pacific, Asia, and internationally.
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential and fair value.
Similar Companies
Share Price & News
How has Demant's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: DEMANT's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
7.3%
DEMANT
4.3%
DK Medical Equipment
11.1%
DK Market
1 Year Return
-24.0%
DEMANT
13.2%
DK Medical Equipment
3.1%
DK Market
Return vs Industry: DEMANT underperformed the Danish Medical Equipment industry which returned 10.4% over the past year.
Return vs Market: DEMANT underperformed the Danish Market which returned 1.7% over the past year.
Shareholder returns
| DEMANT | Industry | Market | |
|---|---|---|---|
| 7 Day | 7.3% | 4.3% | 11.1% |
| 30 Day | -27.1% | -1.1% | -5.1% |
| 90 Day | -28.2% | 8.3% | -7.5% |
| 1 Year | -24.0%-24.0% | 14.6%13.2% | 6.3%3.1% |
| 3 Year | 2.5%2.5% | 81.4%72.9% | 34.9%23.6% |
| 5 Year | 30.1%30.1% | 110.4%92.9% | 29.2%12.7% |
Price Volatility Vs. Market
How volatile is Demant's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
How Much is Demant A/S's (CPH:DEMANT) CEO Getting Paid?1 month ago | Simply Wall St
Does Demant A/S (CPH:DEMANT) Have A Good P/E Ratio?1 month ago | Simply Wall St
Here's What Analysts Are Forecasting For Demant A/S After Its Full-Year ResultsValuation
Is Demant undervalued compared to its fair value and its price relative to the market?
15.5%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: DEMANT (DKK150.6) is trading below our estimate of fair value (DKK178.29)
Significantly Below Fair Value: DEMANT is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: DEMANT is good value based on its PE Ratio (25.1x) compared to the Medical Equipment industry average (37.1x).
PE vs Market: DEMANT is poor value based on its PE Ratio (25.1x) compared to the Danish market (12.2x).
Price to Earnings Growth Ratio
PEG Ratio: DEMANT is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: DEMANT is good value based on its PB Ratio (4.7x) compared to the DK Medical Equipment industry average (6.1x).
Next Steps
Future Growth
How is Demant forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
14.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DEMANT's forecast earnings growth (14.7% per year) is above the savings rate (-0.3%).
Earnings vs Market: DEMANT's earnings (14.7% per year) are forecast to grow faster than the Danish market (11.9% per year).
High Growth Earnings: DEMANT's earnings are forecast to grow, but not significantly.
Revenue vs Market: DEMANT's revenue (8.5% per year) is forecast to grow faster than the Danish market (6% per year).
High Growth Revenue: DEMANT's revenue (8.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DEMANT's Return on Equity is forecast to be high in 3 years time (24%)
Next Steps
Past Performance
How has Demant performed over the past 5 years?
5.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DEMANT has high quality earnings.
Growing Profit Margin: DEMANT's current net profit margins (9.8%) are lower than last year (13.1%).
Past Earnings Growth Analysis
Earnings Trend: DEMANT's earnings have grown by 5.5% per year over the past 5 years.
Accelerating Growth: DEMANT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: DEMANT had negative earnings growth (-19.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-17.2%).
Return on Equity
High ROE: DEMANT's Return on Equity (19.2%) is considered low.
Next Steps
Financial Health
How is Demant's financial position?
Financial Position Analysis
Short Term Liabilities: DEMANT's short term assets (DKK6.9B) do not cover its short term liabilities (DKK8.8B).
Long Term Liabilities: DEMANT's short term assets (DKK6.9B) exceed its long term liabilities (DKK5.3B).
Debt to Equity History and Analysis
Debt Level: DEMANT's debt to equity ratio (105%) is considered high.
Reducing Debt: DEMANT's debt to equity ratio has increased from 62.8% to 105% over the past 5 years.
Debt Coverage: DEMANT's debt is well covered by operating cash flow (26.8%).
Interest Coverage: DEMANT's interest payments on its debt are well covered by EBIT (15.6x coverage).
Balance Sheet
Inventory Level: DEMANT has a high level of physical assets or inventory.
Debt Coverage by Assets: DEMANT's debt is not covered by short term assets (assets are 0.9x debt).
Next Steps
Dividend
What is Demant's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DEMANT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate DEMANT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DEMANT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DEMANT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DEMANT's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.2yrs
Average board tenure
CEO
Søren Nielsen (49yo)
2.83s
Tenure
ø14,700,000
Compensation
Mr. Søren Nielsen has been the Chief Executive Officer and President of William Demant Holding A/S since April 1, 2017 and has been its Member of Executive Board since September 1, 2015 and President of Ot ...
CEO Compensation Analysis
Compensation vs Market: Søren's total compensation ($USD2.17M) is about average for companies of similar size in the Danish market ($USD2.36M).
Compensation vs Earnings: Søren's compensation has been consistent with company performance over the past year.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Deputy Chairman | 2.83yrs | no data | 0.42% DKK150.8m | |
| Chairman | 3.17yrs | no data | 0.0034% DKK1.2m | |
| Independent Director | 4.17yrs | no data | 0.0094% DKK3.4m | |
| Director | 3yrs | no data | 0.00015% DKK54.3k | |
| Independent Director | 6.17yrs | no data | 0.0013% DKK452.9k | |
| Director | 5.17yrs | no data | 0.00055% DKK199.3k | |
| Director | 1.17yrs | no data | 0.00021% DKK76.1k | |
| Director | no data | no data | no data |
3.2yrs
Average Tenure
51yo
Average Age
Experienced Board: DEMANT's board of directors are considered experienced (3.2 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Demant A/S's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Demant A/S
- Ticker: DEMANT
- Exchange: CPSE
- Founded: 1904
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: ø36.229b
- Shares outstanding: 240.56m
- Website: https://www.demant.com
Number of Employees
Location
- Demant A/S
- Kongebakken 9
- Smørum
- Capital Region of Denmark
- 2765
- Denmark
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| WILL.F | OTCPK (Pink Sheets LLC) | Yes | Share Capital | US | USD | May 1995 |
| DEMANT | CPSE (OMX Nordic Exchange Copenhagen) | Yes | Share Capital | DK | DKK | May 1995 |
| WDH1 | DB (Deutsche Boerse AG) | Yes | Share Capital | DE | EUR | May 1995 |
| 0RGT | LSE (London Stock Exchange) | Yes | Share Capital | GB | DKK | May 1995 |
| WILY.Y | OTCPK (Pink Sheets LLC) | UNSPONSORED ADS | US | USD | Nov 2008 |
Biography
Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people’s hearing in Europe, North America, the Pacific, Asia, and internationally. Its products include hearing devices and implants; diagnostic products; and communication systems, such as headsets and solutions for the professional call center and office market, as well as headsets for the gaming and mobile music segments. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/03/31 20:43 |
| End of Day Share Price | 2020/03/31 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.